Страна: Израиль
Язык: английский
Источник: Ministry of Health
CEFUROXIME AS SODIUM SALT
NEOPHARM (ISRAEL) 1996 LTD
J01DC02
POWDER FOR SOLUTION OR SUSPENSION FOR INJECTION OR INFUSION
CEFUROXIME AS SODIUM SALT 750 MG
I.M, I.V
Required
LABESFAL - LABORATORIOS ALMIRO S.A, FRESENIUS KABI GROUP, PORTUGAL
CEFUROXIME
CEFUROXIME
Cefuroxime -Fresenius is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth).• Community acquired pneumonia• Acute exacerbations of chronic bronchitis• Complicated urinary tract infections, including pyelonephritis• Soft-tissue infections: cellulitis, erysipelas and wound infections• Intra-abdominal infections • Prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section)• Nose infections for example, sinusitis• Septic arthritis
2018-01-31
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT CEFUROXIME -FRESENIUS 750 MG CEFUROXIME -FRESENIUS 1500 MG 2. QUALITATIVE AND QUANTITATIVE COMPOSITION CEFUROXIME -FRESENIUS 750 MG Each vial contains 750 mg of cefuroxime (as 789 mg cefuroxime sodium). Each vial contains 40.63 mg of sodium. For the full list of excipients, see section 6.1 CEFUROXIME -FRESENIUS 1500 MG Each vial contains 1500 mg of cefuroxime (as 1578 mg cefuroxime sodium) Each vial contains 81.26 mg of sodium . For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM CEFUROXIME -FRESENIUS 750 MG Powder for solution or suspension for injection or infusion CEFUROXIME -FRESENIUS 1500 MG Powder for solution for inj /inf White or almost white powder 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS CEFUROXIME-FRESENIUS is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth) (see sections 4.4 and 5.1). • Community acquired pneumonia • Acute exacerbations of chronic bronchitis • Complicated urinary tract infections, including pyelonephritis • Soft-tissue infections: cellulitis, erysipelas and wound infections • Intra-abdominal infections (see section 4.4) • Prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section) • Nose infections for example, sinusitis • Septic arthritis In the treatment and prevention of infections in which it is very likely that anaerobic organisms will be encountered, cefuroxime should be administered with additional appropriate antibacterial agents. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY _Table 1. Adults and children ≥ 40 kg _ INDICATION DOSAGE Community acquired pneumonia and acute exacerbations of chronic bronchitis 750 mg every 8 hours (intravenously or intramuscularly) Soft-tissue infections: cellulitis, Прочитать полный документ